德琪医药-B 港股通 空最新回购 (2025-09-16) 官网 ( 06996.hk) | -9.59 | 2.78 | 0% | 上市时间2020-11-20股价3.44港币涨跌幅-1.15%成交金额545.22万港币换手率0.23%市值23.37亿港币H股市值23.37亿港币总股本6.79亿H股本6.79亿每手股数500上市至今年化投资收益率-27.40%港股通持仓占H股比例1.42% (3,445.01万港币2026-01-23) 累计做空占H股比例1.25% (3,454.29万港币2026-01-16) | |||
| 所属三级行业药品 (恒生) | 市盈率 | 32.51 | 市净率 | 3.14 | 股息率 | 1.04% | 恒生:医疗保健业药品及生物科技药品 |
| 备注 (1): | 双击编辑备注 |
德琪医药-B(06996) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | FONSECA Rafael | Independent Non Executive Director | 2023-04-14 | -- | |
| 2 | 劉逸倫 | Non Executive Director | 2021-12-16 | 2023-04-14 | |
| 3 | 龍振國 | Executive Director | 2021-06-18 | -- | |
| 4 | LYNCH Kevin Patrick | Executive Director | 2021-06-18 | 2022-12-16 | |
| 5 | 陳侃 | Non Executive Director | 2021-03-26 | -- | |
| 6 | 錢晶 | Independent Non Executive Director | 2020-11-09 | -- | |
| 7 | 唐晟 | Independent Non Executive Director - A/F | 2020-11-09 | -- | |
| 8 | CHIN John Francis | Executive Director | 2020-08-18 | -- | |
| 9 | ALLES Mark John | Independent Non Executive Director | 2020-01-02 | 2023-04-14 | |
| 10 | 曹彥凌 | Non Executive Director | 2019-02-04 | 2021-12-16 | |
| 11 | 李甄 | Non Executive Director | 2019-02-04 | 2021-06-18 | |
| 12 | 劉翼騰 | Executive Director | 2018-11-22 | 2021-06-18 | |
| 13 | 胡旭波 | Non Executive Director | 2018-11-22 | 2021-03-26 | |
| 14 | 梅建明 | Executive Director | Chairman, CEO | 2018-08-28 | -- |